LongGame

LongGame is a London-based venture capital firm dedicated to funding radical lifespan extension for everyone. They invest in companies aiming for significant advancements in life extension, focusing on scalable solutions that benefit society as a whole, ensuring longevity is accessible to all, not just a select few. Integrity and evidence guide their investments, prioritizing companies with strong ethical foundations and robust scientific backing.

Their portfolio includes companies like Syntax Bio, which is developing a platform to accelerate cell differentiation for organoids, drug testing, and cell therapies, and Lucis Life, aiming to deliver data-driven, personalized longevity insights and interventions to the mainstream.

Founded in 2024, LongGame is led by General Partner and Chief Investment Officer Will Harborne and Chief Scientific Officer Partner Manish Chamoli. The firm is committed to pioneering a future where extended, healthy lifespans are a reality for all.